These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21843306)

  • 1. Behaviour and metabolic control in children with Type 1 diabetes mellitus on insulin pump therapy: 2-year follow-up.
    Knight SJ; Northam EA; Cameron FJ; Ambler GR
    Diabet Med; 2011 Sep; 28(9):1109-12. PubMed ID: 21843306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does insulin pump therapy offer benefits for behaviour, mood, cognition and HbA1c in children and adolescents with type 1 diabetes? A randomised controlled trial with observational follow-up.
    O'Connell MA; Northam EA; Brown A; Papoutsis J; Schuster T; Skinner T; Jenkins AJ; Ambler GR; Cameron FJ
    Arch Dis Child; 2024 Sep; 109(10):806-811. PubMed ID: 38237958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study.
    Knight S; Northam E; Donath S; Gardner A; Harkin N; Taplin C; Joy P; Cameron FJ; Ambler GR
    Diabetologia; 2009 Feb; 52(2):193-8. PubMed ID: 18987843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
    Bell DS; Ovalle F
    Endocr Pract; 2000; 6(5):357-60. PubMed ID: 11141585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
    Conget I; Battelino T; Giménez M; Gough H; Castañeda J; Bolinder J;
    Diabetes Technol Ther; 2011 Jan; 13(1):49-54. PubMed ID: 21175271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)].
    Olsovský J; Beránek M
    Vnitr Lek; 2007 Jun; 53(6):637-45. PubMed ID: 17702123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
    Grant P; Dworakowska D; DeZoysa N; Barnes D
    Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.
    Liberatore R; Perlman K; Buccino J; Artiles-Sisk A; Daneman D
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):223-6. PubMed ID: 15055358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.
    Fox LA; Buckloh LM; Smith SD; Wysocki T; Mauras N
    Diabetes Care; 2005 Jun; 28(6):1277-81. PubMed ID: 15920039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.
    Danne T; Battelino T; Jarosz-Chobot P; Kordonouri O; Pánkowska E; Ludvigsson J; Schober E; Kaprio E; Saukkonen T; Nicolino M; Tubiana-Rufi N; Klinkert C; Haberland H; Vazeou A; Madacsy L; Zangen D; Cherubini V; Rabbone I; Toni S; de Beaufort C; Bakker-van Waarde W; van den Berg N; Volkov I; Barrio R; Hanas R; Zumsteg U; Kuhlmann B; Aebi C; Schumacher U; Gschwend S; Hindmarsh P; Torres M; Shehadeh N; Phillip M;
    Diabetologia; 2008 Sep; 51(9):1594-601. PubMed ID: 18592209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.